PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE Healthcare Offers Nuclear Medicine Clinicians its Latest Xeleris* Software - GE Healthcare announced that it has received FDA clearance of its latest Xeleris† Processing and Review workstation software, adding to one of the most innovative suites of Molecular Imaging solutions in the industry.
GE Healthcare Offers Nuclear Medicine Clinicians its Latest Xeleris* Software

 

NewswireToday - /newswire/ - Vancouver, British Columbia, Canada, 2013/06/10 - GE Healthcare announced that it has received FDA clearance of its latest Xeleris† Processing and Review workstation software, adding to one of the most innovative suites of Molecular Imaging solutions in the industry.. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Today at the Society of Nuclear Medicine and Molecular Imaging meeting, GE Healthcare announced that it has received FDA clearance of its latest Xeleris† Processing and Review workstation software, adding to one of the most innovative suites of Molecular Imaging solutions in the industry.

The latest release of Xeleris enables automation, personalization, access and advanced applications. Nuclear Medicine clinicians will gain access to specific image results where and when they are needed. The availability of Xeleris applications extends not only to GE Centricity PACS systems and Xeleris Floating clients (XFL), but now includes an open application for virtually any PACS and the GE AW Server workstation environment.

“I’m excited to present the new Xeleris to our customers,” said Nathan Hermony, General Manager, Nuclear Medicine, GE Healthcare. “The personalized workflow and unique new clinical applications will give clinicians the information they demand with speed, convenience and flexibility.”

The new Xeleris release includes next generation of DaTQUANT**, which enables visual evaluation and quantification of 123I Ioflupane images and comparison to values in a normal population database. This application provides tools to analyze dopaminergic neuron terminal binding and differences between multiple scans, comparison with a user-chosen database of suitable age-matched reference values, and may provide adjunct information to physicians assessing patients for Parkinson’s disease.

Hermony added,“GE continues to bring innovative products to meet not only the technical, but also the clinical needs of the Molecular Imaging community. As healthcare continues to evolve, we are a family of businesses in a unique position to deliver value in personalized disease management strategies.”

* Trademark of General Electric Company
** DaTQUANT is available for sale only for countries where Ioflupane (I123) pharmaceutical is approved for use. It is not available for sale in Canada.
† Xeleris 3.1 is not available for sale in Canada and has not yet been licensed by Health Canada. Xeleris 3.1 is not commercially available for sale in every region.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare Offers Nuclear Medicine Clinicians its Latest Xeleris* Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

GE News Center |
Publisher Contact: Michael Tetuan - GE Healthcare 
414-721-3006 michael.tetuan[.]ge.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From General Electric Company / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)